Astrana Health (ASTH) to Release Quarterly Earnings on Tuesday

Astrana Health (NASDAQ:ASTHGet Free Report) will be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect Astrana Health to post earnings of $0.32 per share for the quarter. Astrana Health has set its FY24 guidance at $1.28-$1.52 EPS and its FY 2024 guidance at 1.280-1.520 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Astrana Health (NASDAQ:ASTHGet Free Report) last posted its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.09. The firm had revenue of $353.00 million for the quarter, compared to the consensus estimate of $341.17 million. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The business’s revenue for the quarter was up 20.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.02 EPS. On average, analysts expect Astrana Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Astrana Health Price Performance

NASDAQ ASTH traded up $0.35 on Wednesday, hitting $37.50. 17,320 shares of the company were exchanged, compared to its average volume of 154,640. The company’s 50 day moving average price is $40.77. The company has a quick ratio of 2.11, a current ratio of 2.11 and a debt-to-equity ratio of 0.42. The company has a market cap of $2.10 billion, a price-to-earnings ratio of 28.18, a P/E/G ratio of 1.24 and a beta of 1.09. Astrana Health has a twelve month low of $28.86 and a twelve month high of $45.71.

Analyst Upgrades and Downgrades

ASTH has been the topic of a number of research reports. Jefferies Financial Group initiated coverage on Astrana Health in a report on Monday, February 26th. They issued a “buy” rating and a $50.00 target price on the stock. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st.

Check Out Our Latest Analysis on ASTH

About Astrana Health

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Stories

Earnings History for Astrana Health (NASDAQ:ASTH)

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.